Literature DB >> 15921704

The ischemic rat heart releases S100B.

Guilherme S Mazzini1, Débora V Schaf, Alvaro R Oliveira, Carlos A Gonçalves, Adriane Belló-Klein, Solange Bordignon, Ricardo S Bruch, Guilherme F Campos, Dalton V Vassallo, Diogo O Souza, Luis V C Portela.   

Abstract

S100B is an astrocytic protein assessed in cerebrospinal fluid and serum as a biochemical marker of cerebral injuries. However, increasing evidences suggest the influence of extra cerebral sources on its serum levels. Since it was reported that the injured myocardium expresses S100B, we investigated whether the isolated heart releases this protein. The rat hearts were excised and perfused by the Langendorff technique of isolated heart perfusion. After stabilization, 10 hearts (ischemic group) were submitted to 20 minutes of ischemia and 30 minutes of reperfusion, and 5 hearts (control group) were submitted to 50 minutes of perfusion. The perfusion fluid was collected at pre-ischemia, and 0, 5, 10, 15 and 30 min after ischemia (or equivalent in controls) for S100B and cardiac troponin T (a heart injury marker) assays. In the ischemic group, S100B and troponin T levels increased significantly at time 0 min: S100B values [mug/L, median (IQ25/IQ75)] increased from < or = 0.02 (< or = 0.02/0.03) to 0.38 (0.22/0.84), while troponin T values [mug/L, median (IQ25/IQ75)] increased from 0.31 (0.15/0.45) to 2.84 (2.00/3.63). Our results point to the ischemic heart as an extra cerebral source of S100B.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15921704     DOI: 10.1016/j.lfs.2004.12.035

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

1.  TD-11 workshop report: characterization of monoclonal antibodies to S100 proteins.

Authors:  Elisabeth Paus; Mads Haugland Haugen; Kari Hauge Olsen; Kjersti Flatmark; Gunhild Mari Maelandsmo; Olle Nilsson; Eva Röijer; Maria Lundin; Christian Fermér; Maria Samsonova; Yuri Lebedin; Torgny Stigbrand
Journal:  Tumour Biol       Date:  2010-07-24

Review 2.  Current status of fluid biomarkers in mild traumatic brain injury.

Authors:  Jacqueline R Kulbe; James W Geddes
Journal:  Exp Neurol       Date:  2015-05-14       Impact factor: 5.330

3.  Correlation between Amitriptyline-Induced Cardiotoxic Effects and Cardiac S100b Protein in Isolated Rat Hearts.

Authors:  Nil Hocaoğlu; Nergis Murat; Serap Cilaker Mıcılı; Burç Aydın; Bekir Uğur Ergür; Şule Kalkan
Journal:  Balkan Med J       Date:  2016-11-01       Impact factor: 2.021

Review 4.  S100A1: a multifaceted therapeutic target in cardiovascular disease.

Authors:  David Rohde; Julia Ritterhoff; Mirko Voelkers; Hugo A Katus; Thomas G Parker; Patrick Most
Journal:  J Cardiovasc Transl Res       Date:  2010-07-20       Impact factor: 4.132

Review 5.  S100A1 in cardiovascular health and disease: closing the gap between basic science and clinical therapy.

Authors:  Carolin Kraus; David Rohde; Christian Weidenhammer; Gang Qiu; Sven T Pleger; Mirko Voelkers; Melanie Boerries; Andrew Remppis; Hugo A Katus; Patrick Most
Journal:  J Mol Cell Cardiol       Date:  2009-06-16       Impact factor: 5.000

6.  Serum S100B but not NSE levels are increased in morbidly obese individuals affected by obstructive sleep apnea-hypopnea syndrome.

Authors:  Leandro Giacometti da Silva; Cláudio Corá Mottin; Diogo Onofre Souza; Luiz Valmor Portela; Carla Winei Braga; Carolina Boeira Vargas; Alexandre Vontobel Padoin; Denis Martinez; Renato Dutra Dias
Journal:  Obes Surg       Date:  2008-04-18       Impact factor: 4.129

Review 7.  Functions of S100 proteins.

Authors:  R Donato; B R Cannon; G Sorci; F Riuzzi; K Hsu; D J Weber; C L Geczy
Journal:  Curr Mol Med       Date:  2013-01       Impact factor: 2.222

8.  S100B protein expression in the heart of deceased individuals by overdose: a new forensic marker?

Authors:  Armando Faa; Giancarlo Senes; Annalisa Locci; Pietro Pampaloni; Maria Elena Pais; Bruno Piras; Ernesto d'Aloja; Gavino Faa
Journal:  Clinics (Sao Paulo)       Date:  2012-07       Impact factor: 2.365

9.  How does extracerebral trauma affect the clinical value of S100B measurements?

Authors:  Søren Ohrt-Nissen; Lennart Friis-Hansen; Benny Dahl; Jakob Stensballe; Bertil Romner; Lars S Rasmussen
Journal:  Emerg Med J       Date:  2010-10-14       Impact factor: 2.740

10.  S100B Serum Levels Predict Treatment Response in Patients with Melancholic Depression.

Authors:  Oliver Ambrée; Veerle Bergink; Laura Grosse; Judith Alferink; Hemmo A Drexhage; Matthias Rothermundt; Volker Arolt; Tom K Birkenhäger
Journal:  Int J Neuropsychopharmacol       Date:  2015-09-12       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.